BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $2.44M invested in Benitec Biopharma in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.7K
2
+$2.76K

Top Sellers

1
-$67.9K
2
-$31.5K
3
-$26.9K
4
TSS
Two Sigma Securities
New York
-$9.36K
5
Jane Street
Jane Street
New York
-$4.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.1M
2
$161K
3
$47K
4
$45.3K
5
$26K
6
$15.7K
7
$10.1K
8
$9.55K
9
$5.61K
10
$5.26K
11
$4.5K
12
$2.76K
13
$2.72K
14
$2.59K
15
$2.48K
16
$2K
17
$315
18
$80
19
$73
20
$41
21
–
22
–
23
–
24
–